Last reviewed · How we verify
BCMA-GPRC5D CART — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BCMA-GPRC5D CART (BCMA-GPRC5D CART) — Guangzhou Bio-gene Technology Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BCMA-GPRC5D CART TARGET | BCMA-GPRC5D CART | Guangzhou Bio-gene Technology Co., Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BCMA-GPRC5D CART CI watch — RSS
- BCMA-GPRC5D CART CI watch — Atom
- BCMA-GPRC5D CART CI watch — JSON
- BCMA-GPRC5D CART alone — RSS
Cite this brief
Drug Landscape (2026). BCMA-GPRC5D CART — Competitive Intelligence Brief. https://druglandscape.com/ci/bcma-gprc5d-cart. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing